155 related articles for article (PubMed ID: 24593861)
1. The Northwick Park Heart Study: evidence from the laboratory.
Ten Cate H; Meade T
J Thromb Haemost; 2014 May; 12(5):587-92. PubMed ID: 24593861
[TBL] [Abstract][Full Text] [Related]
2. Coagulation factor VII and the risk of coronary heart disease in healthy men.
Junker R; Heinrich J; Schulte H; van de Loo J; Assmann G
Arterioscler Thromb Vasc Biol; 1997 Aug; 17(8):1539-44. PubMed ID: 9301633
[TBL] [Abstract][Full Text] [Related]
3. Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men.
Ken-Dror G; Drenos F; Humphries SE; Talmud PJ; Hingorani AD; Kivimäki M; Kumari M; Bauer KA; Morrissey JH; Ireland HA
J Thromb Haemost; 2010 Nov; 8(11):2394-403. PubMed ID: 20735728
[TBL] [Abstract][Full Text] [Related]
4. Thrombin generation markers and coronary heart disease risk factors in a Polish population sample.
Musiał J; Pajak A; Undas A; Kawalec E; Topór-Madry R; Pazucha T; Grzywacz M; Szczeklik A
Thromb Haemost; 1997 Apr; 77(4):697-700. PubMed ID: 9134645
[TBL] [Abstract][Full Text] [Related]
5. Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.
Danielsen R; Onundarson PT; Thors H; Vidarsson B; Morrissey JH
Scand Cardiovasc J; 1998; 32(2):87-95. PubMed ID: 9636964
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I).
De Stavola BL; Meade TW
J Thromb Haemost; 2007 Mar; 5(3):461-71. PubMed ID: 17137470
[TBL] [Abstract][Full Text] [Related]
7. Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.
Scarabin PY; Vissac AM; Kirzin JM; Bourgeat P; Amiral J; Agher R; Guize L
Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1170-6. PubMed ID: 8792771
[TBL] [Abstract][Full Text] [Related]
8. Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial.
Rudnicka AR; Mt-Isa S; Meade TW
J Thromb Haemost; 2006 Nov; 4(11):2405-10. PubMed ID: 17002654
[TBL] [Abstract][Full Text] [Related]
9. Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis.
Spronk HMH; Padro T; Siland JE; Prochaska JH; Winters J; van der Wal AC; Posthuma JJ; Lowe G; d'Alessandro E; Wenzel P; Coenen DM; Reitsma PH; Ruf W; van Gorp RH; Koenen RR; Vajen T; Alshaikh NA; Wolberg AS; Macrae FL; Asquith N; Heemskerk J; Heinzmann A; Moorlag M; Mackman N; van der Meijden P; Meijers JCM; Heestermans M; Renné T; Dólleman S; Chayouâ W; Ariëns RAS; Baaten CC; Nagy M; Kuliopulos A; Posma JJ; Harrison P; Vries MJ; Crijns HJGM; Dudink EAMP; Buller HR; Henskens YMC; Själander A; Zwaveling S; Erküner O; Eikelboom JW; Gulpen A; Peeters FECM; Douxfils J; Olie RH; Baglin T; Leader A; Schotten U; Scaf B; van Beusekom HMM; Mosnier LO; van der Vorm L; Declerck P; Visser M; Dippel DWJ; Strijbis VJ; Pertiwi K; Ten Cate-Hoek AJ; Ten Cate H
Thromb Haemost; 2018 Feb; 118(2):229-250. PubMed ID: 29378352
[TBL] [Abstract][Full Text] [Related]
10. Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation.
Carvalho de Sousa J; Azevedo J; Soria C; Barros F; Ribeiro C; Parreira F; Caen JP
Thromb Res; 1988 Jul; 51(2):165-73. PubMed ID: 3187958
[TBL] [Abstract][Full Text] [Related]
11. Factor VII and fibrinogen levels examined by age, sex, and other atherosclerotic risk factors in a Japanese population. The Jichi Medical School Cohort Study.
Ishikawa S; Kario K; Nago N; Kayaba K; Hiraoka J; Matsuo H; Goto T; Miyamoto T; Tsutsumi A; Nakamura Y; Shimada K; Inoue K; Igarashi M
Thromb Haemost; 1997 May; 77(5):890-3. PubMed ID: 9184398
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men.
Zito F; Drummond F; Bujac SR; Esnouf MP; Morrissey JH; Humphries SE; Miller GJ
Circulation; 2000 Oct; 102(17):2058-62. PubMed ID: 11044420
[TBL] [Abstract][Full Text] [Related]
13. Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII.
Bröijersén A; Hamsten A; Silveira A; Fatah K; Goodall AH; Eriksson M; Angelin B; Hjemdahl P
Thromb Haemost; 1996 Aug; 76(2):171-6. PubMed ID: 8865525
[TBL] [Abstract][Full Text] [Related]
14. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study.
Carvalho de Sousa J; Bruckert E; Giral P; Soria C; Truffert J; Mirshahi MC; de Gennes JL; Caen JP
Haemostasis; 1989; 19(2):83-90. PubMed ID: 2731779
[TBL] [Abstract][Full Text] [Related]
15. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen and a Triad of Thrombosis, Inflammation, and the Renin-Angiotensin System in Premature Coronary Artery Disease in Women: A New Insight into Sex-Related Differences in the Pathogenesis of the Disease.
Kryczka KE; Kruk M; Demkow M; Lubiszewska B
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356659
[TBL] [Abstract][Full Text] [Related]
17. Factor VII activation and menopausal status.
Scarabin PY; Bonithon-Kopp C; Bara L; Malmejac A; Guize L; Samama M
Thromb Res; 1990 Jan; 57(2):227-34. PubMed ID: 2315887
[TBL] [Abstract][Full Text] [Related]
18. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.
Meade TW; Mellows S; Brozovic M; Miller GJ; Chakrabarti RR; North WR; Haines AP; Stirling Y; Imeson JD; Thompson SG
Lancet; 1986 Sep; 2(8506):533-7. PubMed ID: 2875280
[TBL] [Abstract][Full Text] [Related]
19. Thrombin generation, fibrin clot formation and hemostasis.
Wolberg AS; Campbell RA
Transfus Apher Sci; 2008 Feb; 38(1):15-23. PubMed ID: 18282807
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment.
Ten Cate H; Guzik TJ; Eikelboom J; Spronk HMH
Cardiovasc Res; 2021 Jul; 117(9):2030-2044. PubMed ID: 32931586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
